PTEN is best known as an antagonist of phosphoinositide 3-kinase (PI3K)/AKT signaling pathway, a major component of the pathological avenues for a wide range of cancers development, including prostate cancer [7]. This evidence concerns the gene PTEN and Familial prostate cancer.